Abstract
Background Data on outcomes and risk factors for Asian patients with advanced chronic kidney disease admitted for heart failure are limited. The purpose of this study was to investigate contemporary racial and socioeconomic disparities in Asian patients with advanced kidney disease admitted for heart failure exacerbation.
Methods This was a retrospective cohort study that utilized data from the National Inpatient Sample between January 2016 and December 2020. Patients who had a primary diagnosis of HF and a concomitant diagnosis of advanced CKD were included. The primary outcome of interest was in-hospital mortality. Secondary outcomes include hospital cost, length of stay, and other clinical outcomes. Weighted multivariable logistic regression was used to adjust for comorbidities.
Results A total of 186,431 admissions for heart failure exacerbation with advanced kidney disease were identified, of which 10.7% (n = 20,006) were of Asian descent. Asian patients had the lowest prevalence of comorbidities compared with all other ethnicities. After adjusting for comorbidities, sex, and age, Whites (OR: 1.11; 95% CI 1.03 to 1.20; p<0.009) had higher odds of mortality, while Black (OR: 0.58; 95% CI 0.53 to 0.63; p< 0.001) and Hispanic patients (OR: 0.69; 95% CI 0.62 to 0.78; p< 0.001) had lower odds of mortality compared to Asian patients.
Conclusion Despite recent efforts to address healthcare inequality, health disparities among Asian patients with HF and CKD remain. The significant difference in odds of mortality and complications, despite a lower comorbidity burden, indicates the importance of further research regarding the possible causality of such disparities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
publically available deidentified data not requiring IRB approval
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
Publically available data
Non-standard Abbreviations and Acronyms
- ECMO
- Extracorporeal membrane oxygenation
- HF
- Heart failure
- IABP
- Intra-aortic balloon pump
- pVAD
- Percutaneous ventricular assist device
- SIRS
- Systemic inflammatory response syndrome